Last $0.09 USD
Change Today 0.00 / 0.00%
Volume 0.0
CALZF On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

calzada ltd (CALZF) Snapshot

Open
$0.09
Previous Close
$0.09
Day High
$0.09
Day Low
$0.09
52 Week High
03/25/14 - $0.10
52 Week Low
10/30/13 - $0.05
Market Cap
35.6M
Average Volume 10 Days
716.6
EPS TTM
--
Shares Outstanding
418.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CALZADA LTD (CALZF)

Related News

No related news articles were found.

calzada ltd (CALZF) Related Businessweek News

No Related Businessweek News Found

calzada ltd (CALZF) Details

Calzada Limited, through its subsidiaries, focuses on developing medical devices for reconstructive surgery and tissue repair incorporating its patented biodegradable polymer technology NovoSorb. Its NovoPore dressing is used for topical negative pressure therapy in the treatment of chronic wounds, such as pressure sores. The company is also developing dermal replacement wound treatment device using the NovoSorb biodegradable temporizing matrix. In addition, it owns AOD9604, a 16 amino acid peptide based on a fragment of the C-terminus end of human growth hormone, which has applications in the treatment of obesity, bone, cartilage, and muscle diseases and repair. Calzada Limited is based in Port Melbourne, Australia.

calzada ltd (CALZF) Top Compensated Officers

Chief Financial Officer and Company Secretary
Total Annual Compensation: A$181.1K
Chief Executive Officer of PolyNovo Biomateri...
Total Annual Compensation: A$235.0K
Chief Executive Officer of Metabolic Pharmace...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

calzada ltd (CALZF) Key Developments

Calzada Limited Reports Consolidated Earnings Results for the Year Ended June 30, 2014

Calzada Limited reported consolidated earnings results for the year ended June 30, 2014. For the period, the company reported net loss after tax of AUD 2,941,975 on revenue of AUD 268,793 for the 2014 financial year. This was an increase of 96% from the prior year loss of AUD 1,497,555. Total revenue of AUD 268,793 remained consistent with the prior year of AUD 278,445. Net loss before income tax was AUD 2,941,975 compared with AUD 1,569,673 for the same period last year. Loss for the period is attributable to owners of the parent was AUD 2,936,379 or 0.71 cents diluted per share compared with AUD 1,492,423 or 0.43 cents diluted per share for the same period last year. Net cash outflows from operating activities were AUD 2,612,850 compared with AUD 2,325,918 for the same period last year. Payments for plant and equipment were AUD 76,320 compared with AUD 13,830 for the same period last year.

Calzada Limited Provides Consolidated Unaudited Earnings Guidance for the Year Ended June 30, 2014

Calzada Limited provided consolidated unaudited earnings guidance for the year ended June 30, 2014. For the period, the company's consolidated financial result is expected to be a loss in the range of AUD 2.450 million to AUD 2.550 million after tax. This is an increase from the prior year's loss of AUD 1.498 million after tax. The increase in loss is predominantly attributable to the recognition in fiscal year 2013 of the Australian Government's research and development incentive for both fiscal year 2012 and fiscal year 2013, whereas this year's result only has a single year's incentive as income.

Calzada Limited, Special/Extraordinary Shareholders Meeting, Jul 01, 2014

Calzada Limited, Special/Extraordinary Shareholders Meeting, Jul 01, 2014., at 09:00 E. Australia Standard Time. Location: Unit 2, 320 Lorimer St. Agenda: To approve the issue of options to Mr. David Williams.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CALZF:US $0.09 USD 0.00

CALZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CALZF.
View Industry Companies
 

Industry Analysis

CALZF

Industry Average

Valuation CALZF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 163.5x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 144.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALZADA LTD, please visit www.metabolic.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.